Chapter 23: Q15P (page 829)
Is trimethoprim a mechanism-based inhibitor of bacterial dihydrofolate reductase?
Short Answer
Trimethoprim is not a mechanism-based inhibitor of bacterial DHFR because it is a reversible inhibitor.
Chapter 23: Q15P (page 829)
Is trimethoprim a mechanism-based inhibitor of bacterial dihydrofolate reductase?
Trimethoprim is not a mechanism-based inhibitor of bacterial DHFR because it is a reversible inhibitor.
All the tools & learning materials you need for study success - in one app.
Get started for freeGout resulting from the de novo overproduction of purines can be distinguished from gout caused by impaired excretion of uric acid by feeding a patient 15N- labeled glycine and determining the distribution of 15Nin his or her excreted uric acid. What isotopic distributions are expected for each type of defect?
The purine and pyrimidine rings are built from the amino acids aspartate, glutamine, and glycine. Why is serine required for the synthesis of deoxyribonucleotides?
What is the role of thioredoxin and NADPH in the formation of deoxyribonucleotides?
Describe how the fumarate produced by the purine nucleotide cycle could be catabolized to CO2.
Describe the reactions catalyzed by nucleoside phosphorylase, adenosine deaminase, and xanthine oxidase.
What do you think about this solution?
We value your feedback to improve our textbook solutions.